Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,721.00 JPY | -0.27% | -7.21% | +5.94% |
04/09 | Nexon Targets 750 Billion Yen in Sales by 2027 | MT |
19/08 | Jefferies Adjusts Nexon's Price Target to 4,870 Yen From 4,340 Yen, Keeps at Buy | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.6 | 9.6 | 6.37 | 6.72 | 7.72 | |||||
Return on Total Capital | 10.82 | 11 | 7.37 | 7.78 | 9.04 | |||||
Return On Equity % | 18.93 | 8.21 | 14.44 | 11.67 | 8.01 | |||||
Return on Common Equity | 19.68 | 8.45 | 14.86 | 11.84 | 8.05 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 76.03 | 76.45 | 73.72 | 70.1 | 67.42 | |||||
SG&A Margin | 26.66 | 27.95 | 29.89 | 30.99 | 28.06 | |||||
EBITDA Margin % | 45.38 | 44.39 | 37.44 | 32.75 | 33.26 | |||||
EBITA Margin % | 42.29 | 41.46 | 34.35 | 30.83 | 31.23 | |||||
EBIT Margin % | 42.29 | 41.46 | 34.35 | 30.83 | 31.23 | |||||
Income From Continuing Operations Margin % | 45.56 | 18.94 | 41.2 | 28.27 | 16.79 | |||||
Net Income Margin % | 46.54 | 19.19 | 41.86 | 28.37 | 16.68 | |||||
Net Avail. For Common Margin % | 46.54 | 19.19 | 41.86 | 28.37 | 16.68 | |||||
Normalized Net Income Margin | 34.62 | 24.19 | 31.49 | 27.24 | 23.87 | |||||
Levered Free Cash Flow Margin | 32.18 | 29.74 | 16.07 | 24.34 | 15.75 | |||||
Unlevered Free Cash Flow Margin | 32.28 | 29.82 | 16.17 | 24.44 | 15.96 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.36 | 0.37 | 0.3 | 0.35 | 0.4 | |||||
Fixed Assets Turnover | 9 | 9.11 | 7.88 | 8.69 | 8.57 | |||||
Receivables Turnover (Average Receivables) | 8.29 | 11.82 | 14.25 | 14.73 | 12.39 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 13.44 | 9.98 | 11.13 | 7.72 | 7.71 | |||||
Quick Ratio | 13.11 | 9.43 | 10.36 | 7.24 | 7.1 | |||||
Operating Cash Flow to Current Liabilities | 2.55 | 2.37 | 1.99 | 1.57 | 1.44 | |||||
Days Sales Outstanding (Average Receivables) | 44.05 | 30.96 | 25.61 | 24.78 | 29.45 | |||||
Average Days Payable Outstanding | 46.55 | 48.85 | 50.66 | 41.51 | 41.06 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 2.04 | 2.3 | 1.81 | 2.69 | 3.28 | |||||
Total Debt / Total Capital | 2 | 2.25 | 1.78 | 2.62 | 3.17 | |||||
LT Debt/Equity | 1.35 | 1.64 | 1.45 | 2.22 | 2.66 | |||||
Long-Term Debt / Total Capital | 1.32 | 1.61 | 1.43 | 2.16 | 2.57 | |||||
Total Liabilities / Total Assets | 12.23 | 16.44 | 14.26 | 16.81 | 17.44 | |||||
EBIT / Interest Expense | 262.1 | 340.32 | 227.2 | 185.48 | 93.76 | |||||
EBITDA / Interest Expense | 281.29 | 364.34 | 247.6 | 196.99 | 99.85 | |||||
(EBITDA - Capex) / Interest Expense | 277.73 | 357.78 | 243.78 | 192.23 | 97.44 | |||||
Total Debt / EBITDA | 0.11 | 0.13 | 0.15 | 0.2 | 0.21 | |||||
Net Debt / EBITDA | -4.42 | -3.91 | -5.06 | -4.74 | -4.03 | |||||
Total Debt / (EBITDA - Capex) | 0.12 | 0.13 | 0.15 | 0.21 | 0.22 | |||||
Net Debt / (EBITDA - Capex) | -4.47 | -3.99 | -5.14 | -4.85 | -4.13 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -2.04 | 17.9 | -6.33 | 28.88 | 19.69 | |||||
Gross Profit, 1 Yr. Growth % | -3.68 | 18.55 | -9.68 | 22.53 | 15.12 | |||||
EBITDA, 1 Yr. Growth % | -0.71 | 15.31 | -21 | 12.73 | 21.55 | |||||
EBITA, 1 Yr. Growth % | -1.91 | 15.6 | -22.4 | 15.67 | 21.21 | |||||
EBIT, 1 Yr. Growth % | -1.91 | 15.6 | -22.4 | 15.67 | 21.21 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 9.96 | -51 | 103.76 | -11.56 | -28.91 | |||||
Net Income, 1 Yr. Growth % | 7.42 | -51.39 | 104.35 | -12.66 | -29.63 | |||||
Normalized Net Income, 1 Yr. Growth % |